Bill Ackman is about to hold a call defending his position in Valeant Pharmaceuticals.
And ahead of this call, Herbalife, the nutritional supplement company Ackman is famously betting against and has called a pyramid scheme that will see its stock go to $0, just took a massive shot at Ackman.
In a one sentence press release, Herbalife said:
“I hope Bill Ackman has done more research on Valeant than he did on Herbalife, Target, Borders and JC Penny (sic), ” said Alan Hoffman, executive vice president, global corporate affairs, Herbalife.
READ MORE: Bill Ackman
John Petrides, MD and portfolio manager at Point View Wealth Management, says it might not be a wise decision to follow Bill Ackman and Valeant stock. More…
Bill Ackman’s Pershing Square Capital, got pounded in September. The hedge fund was the best-performing last year, returning 40.4%. Last month the fund’s publicly traded vehicle, fell 12.5% for the More…